A pharmacovigilance committee is investigating a potential pharmacological trigger for acute angle-closure glaucoma (AACG). Recent post-marketing surveillance reports suggest that the ingestion of over-the-counter oral sympathomimetic decongestants may precipitate an acute attack of AACG within 24 hours of use. AACG is a rare, vision-threatening emergency strongly associated with static, individualized anatomical risk factors—such as a narrow iridocorneal angle and a short axial length—which are difficult to systematically measure across large populations. The investigators aim to quantify the short-term risk associated with decongestant use while completely eliminating the confounding effects of these unmeasured, static between-person differences.
Which of the following is the most appropriate study design for this investigation?
- Case-crossover studyCevap
- BNested case-control study
- CRandomized crossover trial
- DRetrospective cohort study
- EClassical case-control study